Featured Stories
BIAL and Medis entered into a partnership for innovative medicines for the central nervous system
BIAL and Medis announce that they have entered into an exclusive partner-ship on two BIAL's proprietary medicines eslicarbazepine acetate and opicapone.
Read More
Heartily for a better tomorrow, interview with Marija Delimar, director of Medis Adria d.o.o., Croatia
In more than 30 years of business, Medis has established important cooperation with leading global pharmaceutical and biotechnological companies. We talked with...
Read More
To Celebrate the 15th Anniversary of Medis International BiH, the Employees Planted 15 Conifers on the Slopes of Igman
On this occasion, the Bosnian Medis team briefly left the offices and replaced the office environment with nature.
Read More
Medis' Bold Strategy Opens Up Access to Cutting-Edge Innovative Medicines in the CEE Region
Strategic business units reflect focus, expertise and reliable service. Medis rebranding reveals passion and compassion to address the emerging healthcare needs...
Read More
With a redesigned image and a stronger heart boldly into the future
The rebranding goes hand in hand with our 2025 corporate strategy to further strengthen our business, corporate reputation and connection with all stakeholders...
Read More
United at last! Medis is transitioning to the medis.com global domain
The Medis company is transitioning to the medis.com global domain which also applies to employee e-mails.
Read More